Long Noncoding RNA from PVT1 Exon 9 Is Overexpressed in Prostate Cancer and Induces Malignant Transformation and Castration Resistance in Prostate Epithelial Cells

被引:27
作者
Pal, Gargi [1 ]
Huaman, Jeannette [1 ]
Levine, Fayola [1 ]
Orunmuyi, Akintunde [2 ]
Olapade-Olaopa, E. Oluwabunmi [3 ]
Onagoruwa, Onayemi T. [1 ]
Ogunwobi, Olorunseun O. [1 ,4 ]
机构
[1] CUNY Hunter Coll, Dept Biol Sci, New York, NY 10065 USA
[2] Univ Ibadan, Coll Med, Nucl Med Dept, Ibadan 200222, Nigeria
[3] Univ Ibadan, Coll Med, Dept Surg, Urol Div, Ibadan 200222, Nigeria
[4] Cornell Univ, Joan & Sanford I Weill Dept Med, Weill Cornell Med, New York, NY 10021 USA
关键词
PVT1; exon; 9; prostate cancer; malignant transformation; castration resistance; ANDROGEN DEPRIVATION THERAPY; LNCRNA PVT1; INCREASED EXPRESSION; POOR-PROGNOSIS; BIOMARKER; SURVIVAL; AMPLIFICATION; PROGRESSION; ABIRATERONE; GROWTH;
D O I
10.3390/genes10120964
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Prostate cancer (PCa) is the most common non-cutaneous cancer and second leading cause of cancer-related death for men in the United States. The nonprotein coding gene locus plasmacytoma variant translocation 1 (PVT1) is located at 8q24 and is dysregulated in different cancers. PVT1 gives rise to several alternatively spliced transcripts and microRNAs. There are at least twelve exons of PVT1, which make separate transcripts, and likely have different functions. Here, we demonstrate that PVT1 exon 9 is significantly overexpressed in PCa tissues in comparison to normal prostate tissues. Both transient and stable overexpression of PVT1 exon 9 significantly induced greater prostate epithelial cell migration, as well as increased proliferation and corresponding proliferating cell nuclear antigen (PCNA) expression. Notably, implantation into mice of a non-tumorigenic prostate epithelial cell line stably overexpressing PVT1 exon 9 resulted in the formation of malignant tumors. Furthermore, PVT1 exon 9 overexpression significantly induced castration resistance. Consequently, PVT1 exon 9 expression is important for PCa initiation and progression, and holds promise as a therapeutic target in PCa.
引用
收藏
页数:11
相关论文
共 35 条
[1]  
[Anonymous], MOL CLONING LAB MANU
[2]   Common variants at PVT1, ATG13-AMBRA1, AHI1 and CLEC16A are associated with selective IgA deficiency [J].
Bronson, Paola G. ;
Chang, Diana ;
Bhangale, Tushar ;
Seldin, Michael F. ;
Ortmannl, Ward ;
Ferreira, Ricardo C. ;
Urcelay, Elena ;
Fernandez Pereira, Luis ;
Martin, Javier ;
Plebani, Alessandro ;
Lougaris, Vassilios ;
Friman, Vanda ;
Freiberger, Tomas ;
Litzman, Jiri ;
Thon, Vojtech ;
Pan-Hammarstrom, Qiang ;
Hammarstrom, Lennart ;
Graham, Robert R. ;
Behrens, Timothy W. .
NATURE GENETICS, 2016, 48 (11) :1425-1429
[3]   The PVT-1 oncogene is a myc protein target is overexpressed in transformed cells [J].
Carramusa, Letizia ;
Contino, Flavia ;
Ferro, Arianna ;
Minafra, Luigi ;
Perconti, Giovanni ;
Giallongo, Agata ;
Feo, Salvatore .
JOURNAL OF CELLULAR PHYSIOLOGY, 2007, 213 (02) :511-518
[4]   Long noncoding RNA PVT1 promotes EMT via mediating microRNA-186 targeting of Twist1 in prostate cancer [J].
Chang, Zhongwen ;
Cui, Jun ;
Song, Yongsheng .
GENE, 2018, 654 :36-42
[5]   lncRNA PVT1 identified as an independent biomarker for prognosis surveillance of solid tumors based on transcriptome data and meta-analysis [J].
Chen, Xiaoliang ;
Yang, Yueying ;
Cao, Yong ;
Wu, Changjun ;
Wu, Shuxian ;
Su, Zhan ;
Jin, Hongwei ;
Wang, Dongli ;
Zhang, Gengxin ;
Fan, Wei ;
Lin, Jinbo ;
Zeng, Yunhong ;
Hu, Dongsheng .
CANCER MANAGEMENT AND RESEARCH, 2018, 10 :2711-2727
[6]   Promoter of IncRNA Gene PVT1 Is a Tumor-Suppressor DNA Boundary Element [J].
Cho, Seung Woo ;
Xu, Jin ;
Sun, Ruping ;
Mumbach, Maxwell R. ;
Carter, Ave C. ;
Chen, Y. Grace ;
Yost, Kathryn E. ;
Kim, Jeewon ;
He, Jing ;
Nevins, Stephanie A. ;
Chin, Suet-Feung ;
Caldas, Carlos ;
Liu, S. John ;
Horlbec, Max A. ;
Lim, Daniel A. ;
Weissman, Jonathan S. ;
Curtis, Christina ;
Chang, Howard Y. .
CELL, 2018, 173 (06) :1398-+
[7]   Long non-coding RNA PVT1 as a novel biomarker for diagnosis and prognosis of non-small cell lung cancer [J].
Cui, Di ;
Yu, Cai-Hua ;
Liu, Min ;
Xia, Qing-Qing ;
Zhang, Yu-Feng ;
Jiang, Wei-Long .
TUMOR BIOLOGY, 2016, 37 (03) :4127-4134
[8]   Abiraterone and Increased Survival in Metastatic Prostate Cancer [J].
De Bono, Johann S. ;
Logothetis, Christopher J. ;
Molina, Arturo ;
Fizazi, Karim ;
North, Scott ;
Chu, Luis ;
Chi, Kim N. ;
Jones, Robert J. ;
Goodman, Oscar B., Jr. ;
Saad, Fred ;
Staffurth, John N. ;
Mainwaring, Paul ;
Harland, Stephen ;
Flaig, Thomas W. ;
Hutson, Thomas E. ;
Cheng, Tina ;
Patterson, Helen ;
Hainsworth, John D. ;
Ryan, Charles J. ;
Sternberg, Cora N. ;
Ellard, Susan L. ;
Flechon, Aude ;
Saleh, Mansoor ;
Scholz, Mark ;
Efstathiou, Eleni ;
Zivi, Andrea ;
Bianchini, Diletta ;
Loriot, Yohann ;
Chieffo, Nicole ;
Thian Kheoh ;
Haqq, Christopher M. ;
Scher, Howard I. .
NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (21) :1995-2005
[9]   Long non-coding RNA PVT1 is associated with tumor progression and predicts recurrence in hepatocellular carcinoma patients [J].
Ding, Chaofeng ;
Yang, Zhe ;
Lv, Zhen ;
Du, Chengli ;
Xiao, Heng ;
Peng, Chuanhui ;
Cheng, Shaobing ;
Xie, Haiyang ;
Zhou, Lin ;
Wu, Jian ;
Zheng, Shusen .
ONCOLOGY LETTERS, 2015, 9 (02) :955-963
[10]  
Fitzmaurice C., 2016, JAMA Oncol